Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.
- Resource Type
- Article
- Source
- Neuro-Oncology Advances; 2023, Vol. 5 Issue 1, p1-11, 11p
- Subject
- Language